These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28991862)

  • 21. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case records of the Massachusetts General Hospital. Case 30-2008. A 47-year-old woman with a mass in the breast and a solitary lesion in the spine.
    Gradishar WJ; Bellon JR; Gadd MA; D'Alessandro HA; Braaten K
    N Engl J Med; 2008 Sep; 359(13):1382-91. PubMed ID: 18815400
    [No Abstract]   [Full Text] [Related]  

  • 23. Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG).
    Skriver SK; Laenkholm AV; Rasmussen BB; Handler J; Grundtmann B; Tvedskov TF; Christiansen P; Knoop AS; Jensen MB; Ejlertsen B
    Acta Oncol; 2018 Jan; 57(1):31-37. PubMed ID: 29168427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of hormone therapy in patients with hormone receptor positive (HR+) advanced breast cancer.
    Dalmau E; Armengol-Alonso A; Muñoz M; Seguí-Palmer MÁ
    Breast; 2014 Dec; 23(6):710-20. PubMed ID: 25311296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and biological characteristics of breast cancer.
    Kocic B; Filipovic S; Petrovic B; Mijalkovic D; Rancic N; Poultsidi A
    J BUON; 2010; 15(4):660-7. PubMed ID: 21229626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choroidal metastasis in a patient with disseminated breast cancer: hormonal therapy-induced regression.
    El-Saify WM
    Breast J; 2006; 12(5):490-2. PubMed ID: 16958973
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer.
    Recchia F; Candeloro G; Rosselli M; Bratta M; Pasta V; D'Orazi V; Fumagalli LA; Rea S
    Anticancer Res; 2015 Dec; 35(12):6847-53. PubMed ID: 26637906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection and assessment of Ki-67 in breast cancer].
    Shui RH; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):420-3. PubMed ID: 24060083
    [No Abstract]   [Full Text] [Related]  

  • 29. [Selective sentinel node biopsy in breast cancer with contralateral axillary drainage].
    Hernandez Pérez IL; Martínez Lorca A; Santos Gómez I; Sánchez Méndez JI; Ramirez Escalante Y; Marin Ferrer MD
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):77-8. PubMed ID: 25112887
    [No Abstract]   [Full Text] [Related]  

  • 30. Pigmented Cutaneous Metastasis of Breast Carcinoma Mimicking a Melanoma.
    Ubillos N; Vola M; Mazzei ME; Magliano J
    Actas Dermosifiliogr; 2016 Oct; 107(8):699-701. PubMed ID: 27206606
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres.
    Angarita FA; Chesney T; Elser C; Mulligan AM; McCready DR; Escallon J
    Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infiltrating ductal carcinoma of the vulva.
    Kennedy DA; Hermina MS; Xanos ET; Schink JC; Hafez GR
    Pathol Res Pract; 1997; 193(10):723-6. PubMed ID: 9505265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
    Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
    Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neoadjuvant endocrine therapy for postmenopausal estrogen receptor-positive patients with breast cancer].
    Zhang B
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):241-4. PubMed ID: 21575491
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiparametric Genomic Assays for Breast Cancer: Time for the Next Generation?
    Brufsky AM; Davidson NE
    Clin Cancer Res; 2016 Oct; 22(20):4963-4965. PubMed ID: 27521446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
    Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
    Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [How to optimize the clinical therapeutic protocol for triple-positive breast cancer].
    Wang N; Wang YJ
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):241-3. PubMed ID: 20510070
    [No Abstract]   [Full Text] [Related]  

  • 38. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
    Novoa Vargas A; Font López KC; Amador DD
    Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphea following radiation therapy in a patient with breast cancer.
    García-Arpa M; Lozano-Martín E; Rodríguez CR; Rodríguez-Vázquez M
    Actas Dermosifiliogr; 2015 Apr; 106(3):243-5. PubMed ID: 25444581
    [No Abstract]   [Full Text] [Related]  

  • 40. A remarkable case of cutaneous metastatic breast carcinoma.
    Santiago F; Saleiro S; Brites MM; Frutuoso C; Figueiredo A
    Dermatol Online J; 2009 Jul; 15(7):10. PubMed ID: 19903438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.